Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05725837
PHASE2

Effects of Paroxetine on Cardiovascular Function in Septic Patients

Sponsor: Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude

View on ClinicalTrials.gov

Summary

It is known that septic shock is characterized by arterial hypotension, decreased peripheral vascular resistance and hyporeactivity to vasoconstrictor agents, with NO being an important mediator of this organ dysfunction. Data in the literature have shown that hyporeactivity to catecholamines is associated with a decrease in the density of α and ß receptors in the aorta and heart, respectively, as well as an increase in GRK2 levels and that NO contributes to the increase of this kinase in sepsis . Based on this, it is hypothesized that cardiac dysfunction and decreased peripheral vascular resistance observed in sepsis may result from an increase in GRK2 activity and/or expression and its inhibition may be a relevant therapeutic target in septic shock patients. Based on this line, a measurable clinical benefit of paroxetine through the regulation of GRK2 expression in patients with septic shock is postulated.

Official title: Effects of Paroxetine on Cardiovascular Function in Septic Patients: a Randomized Placebo Controlled Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

92

Start Date

2023-06-10

Completion Date

2025-04-15

Last Updated

2025-01-06

Healthy Volunteers

No

Interventions

DRUG

Paroxetine

Paroxetine, 40mg/day, once a day, for 05 consecutive days or 24 hours after shock resolution

Locations (2)

Hospital Maternidade São José de Colatina

Colatina, Espírito Santo, Brazil

Hospital São José

Criciúma, Santa Catarina, Brazil